APOE Genotype Reveals Personalized Dementia Risk Thresholds in Lewy Body Disease

MedAI Digest
MedAI Digest
APOE Genotype Reveals Personalized Dementia Risk Thresholds in Lewy Body Disease
Loading
/

A landmark post-mortem study of 399 brains reveals that APOE genotype fundamentally shapes individual dementia risk thresholds in Lewy body disease, with major implications for patient stratification and personalized treatment.

Original paper: Quantitative pathology and APOE genotype reveal dementia risk and progression in Lewy body disease. — Brain : a journal of neurology. 10.1093/brain/awag114

📄 Read the article

Trending now

Quantitative pathology and APOE genotype reveal dementia risk and progression in Lewy body disease.
APOE Genotype and Protein Pathology Shape Dementia Risk in Lewy Body Disease
Transfer-learning guided design of high-performance conjugated polymers for low-voltage electrochemical transistors.
Machine Learning Accelerates Discovery of Ultra-Low-Voltage Polymers
Soft multiclass feature augmented deep learning to predict tumor origins using cytology or histology whole slide images.
AI Identifies Tumor Origins from Tissue Images with 98% Accuracy
AI-guided multi-omics analysis identifies NPC1-modulated susceptibility to SARS-CoV-2 infection under PM2.5 exposure.
Air Pollution and COVID-19: How NPC1 Mediates SARS-CoV-2 Infection Risk